Product Information
TRIPLE ANTIBIOTIC OINTMENT is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1109 per GM under NDC 51672212002. Its NADAC has been published 538 times since Jun 15, 2016.
Strength
400; 3.5; 5000 [iU]/g; mg/g; [iU]/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672212002
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
12/15/2015
Pharmacological Classes
Price Statistics
The NADAC for TRIPLE ANTIBIOTIC OINTMENT has been published 538 times since Jun 15, 2016, and over the history we have for it it has risen 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1109 per GM |
|---|---|
| All-time high | $0.1150 (Aug 13, 2025) |
| All-time low | $0.0753 (Nov 18, 2020) |
| 52-week high | $0.1109 |
| 52-week low | $0.1039 |
| Median price | $0.0919 |
| Average price | $0.0944 |
| Largest weekly change | +39.2% (Jun 19, 2019) |
| Weeks tracked | 538 |
| Tracking since | Jun 15, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIPLE ANTIBIOTIC OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TRIPLE ANTIBIOTIC OINTMENT, manufactured by Sun Pharmaceutical Industries Inc., is $0.1109 per GM (NDC 51672212002), effective Sep 30, 2026.
How has the price of TRIPLE ANTIBIOTIC OINTMENT changed over time?
Over the history we have for it, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has risen 33.3%. It has been tracked across 538 weekly CMS publications since Jun 15, 2016.
What are the highest and lowest recorded NADAC prices for TRIPLE ANTIBIOTIC OINTMENT?
Since Jun 15, 2016, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has ranged from a low of $0.0753 (Nov 18, 2020) to a high of $0.1150 (Aug 13, 2025), with a median of $0.0919 per GM.
Are there cheaper alternatives to TRIPLE ANTIBIOTIC OINTMENT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIPLE ANTIBIOTIC OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIPLE ANTIBIOTIC OINTMENT?
TRIPLE ANTIBIOTIC OINTMENT (NDC 51672212002) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.